Christopher D. Koprowski

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

Consolidation Carboplatin, Oncology, Radiation Therapy +6

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki et al. · Journal of Clinical Oncology · 2019 · 540 citations · Full text

Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer

Benjamin Movsas, Chen Hu, Jeffrey A. Sloan et al. · JAMA Oncology · 2015 · 177 citations · Full text

Multicenter Phase Ib/II Trial of the Radiation Enhancer Motexafin Gadolinium in Patients With Brain Metastases

Patrice Carde, Robert Timmerman, Minesh P. Mehta et al. · Journal of Clinical Oncology · 2001 · 132 citations

Reduce in Variation and Improve Efficiency of Target Volume Delineation by a Computer-Assisted System Using a Deformable Image Registration Approach

K. S. Clifford Chao, Shreerang Bhide, Hansen Chen et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 131 citations

Engineering, Volume Parameterization, Biomedical Engineering +17